Search by Drug Name or NDC

    NDC 52083-0625-16 ABATUSS DMX 1; 15; 30 mg/5mL; mg/5mL; mg/5mL Details

    ABATUSS DMX 1; 15; 30 mg/5mL; mg/5mL; mg/5mL

    ABATUSS DMX is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Kramer Novis. The primary component is DEXCHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 52083-0625
    Product ID 52083-625_a0f9bf55-af76-4bbb-bb71-648d1f9a0da3
    Associated GPIs 43995803490930
    GCN Sequence Number 069264
    GCN Sequence Number Description dexchlorphenir/pseudoephed/DM LIQUID 1-30-15/5 ORAL
    HIC3 B3R
    HIC3 Description NON-OPIOID ANTITUS-1ST GEN.ANTIHISTAMINE-DECONGEST
    GCN 32254
    HICL Sequence Number 039060
    HICL Sequence Number Description DEXCHLORPHENIRAMINE MALEATE/PSEUDOEPHED/DEXTROMETHORPHAN HBR
    Brand/Generic Generic
    Proprietary Name ABATUSS DMX
    Proprietary Name Suffix n/a
    Non-Proprietary Name DEXCHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PSEUDOEPHEDRINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 1; 15; 30
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name DEXCHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name Kramer Novis
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2023-12-31

    Package

    NDC 52083-0625-16 (52083062516)

    NDC Package Code 52083-625-16
    Billing NDC 52083062516
    Package 1 BOTTLE in 1 CARTON (52083-625-16) / 473 mL in 1 BOTTLE
    Marketing Start Date 2014-05-25
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 6d54ef1e-6722-43f9-a0a7-14a786160b04 Details

    Revised: 10/2022